News

TORONTO, July 18, 2025 (GLOBE NEWSWIRE) — Prime Dividend Corp. (The “Company”) declares its monthly distribution of $0.07108 for each Class A share and $0.06083 f… ...
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- Prime Dividend Corp. (The "Company") declares its monthly distribution of $0.07108 for each Class A share and $0.06083 for each Preferred share ...
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- Canadian Banc Corp. (The "Company") declares its monthly distribution of $0.15075 for each Class A share and $0.05375 for each Preferred share ...
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- Financial 15 Split Corp. ("Financial 15") declares its regular monthly distribution of $0.12570 for each Class A share ($1.51 annualized) and $0.07083 for ...
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. II (“Dividend 15 II”) declares its monthly distribution of $0.10000 for each Class A share and $0.05833 for each Preferred ...
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) — TDb Split Corp. (“TDb Split”) declares its regular monthly distribution of $0.05000 for each Class A share ($0.60 annualized) and $0.05833 for each Priority ...
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- Dividend 15 Split Corp. (The Company) declares its monthly distribution of $0.10000 for each Class A sha ...
GlobeNewswire DIVIDEND 15 SPLIT CORP. Monthly Dividend Declaration for Class A & Preferred Share GlobeNewswire Updated July 18, 2025 9:06 AM ...
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- Dividend 15 Split Corp. II ('Dividend 15 II') declares its monthly distribution of $0.10000 for each Class A share and $0.05833 for each Preferred share.
TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- TDb Split Corp. (TDb Split) declares its regular monthly distribution of $0.05000 for each Class A share ...
DUBLIN - UBS (Irl) Fund Solutions plc announced Thursday it will declare dividends for several distributing share classes of its ETF products for the six-month period ending June 30, 2025.
Find the latest Ophthalmology news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.